CHARLOTTE, N.C., Oct. 20, 2017 -- The Barings Participation Investors (the “Trust”) Board of Trustees met today. The Trust’s Trustees declared a quarterly dividend of 27 cents per share payable on November 10, 2017 to shareholders of record on October 30, 2017. The Trust paid a dividend of 27 cents per share in the preceding quarter.
The Trust’s Trustees determined that the Trust’s net asset value as of September 30, 2017 was $148,640,732 or $14.24 per share based on 10,440,458 shares outstanding. As of September 30, 2016, the Trust’s net assets were $141,496,822 or $13.65 per share based on 10,369,161 shares outstanding. As of June 30, 2017, the Trust’s net assets were $145,538,123 or $13.96 per share based on 10,422,475 shares outstanding.
The Trust’s net investment income for the quarter ended September 30, 2017 was $2,629,867 or $0.25 per share. Net investment income for the quarter ended September 30, 2016 was $2,425,345 or $0.23 per share. For the previous quarter ended June 30, 2017, net investment income was $2,993,697 or $0.29 per share, of which approximately $247,629 or $0.02 per share represented income due to nonrecurring items. Net investment income for the nine months ended September 30, 2017 was $8,600,981 or $0.82 per share, compared with $7,213,975 or $0.70 per share for the comparable period in 2016.
During the quarter ended September 30, 2017, net capital gains of $880,224 or $0.08 per share were realized by the Trust (compared to gains of $733,319 or $0.07 per share for the quarter ended September 30, 2016), bringing 2017 year-to-date net realized capital gains to $2,168,185 or $0.21 per share. During the previous quarter ended June 30, 2017, net capital gains of $954,889 or $0.09 per share were realized by the Trust.
Also, in response to current market conditions, the Trustees agreed to reduce the minimum expected internal rate of return threshold for investments offered to the Trust pursuant to the Trust’s existing co-investment exemptive order.
The market price of Barings Participation Investors as of September 30, 2017 was $14.43, which equates to a 1.13% premium over the September 30, 2017 NAV per share. The Trust’s average quarter-end premium for the 3, 5 and 10-year periods was 1.08%, 2.76% and 6.22%, respectively.
Barings Participation Investors is a closed-end management investment company advised by Barings LLC. Its shares are traded on the New York Stock Exchange under the trading symbol (“MPV”).
Per share amounts are rounded to the nearest cent.
Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date in which they are made and which reflect management’s current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially. These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the fund's trading intent. References to specific securities are not recommendations of such securities, and may not be representative of the fund's current or future investments. We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise.
About Barings
Barings is a leading global financial services firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 600 investment professionals and offices in 16 countries. Learn more at www.barings.com.
Contact:
Brian Whelan, Head of Corporate Communications, 980.417.7700, [email protected]
17/286117


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Washington Post Publisher Will Lewis Steps Down After Layoffs
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



